Sentence examples for blocker compared to the from inspiring English sources

We have recently reported the superiority of afatinib, an irreversible erbB family blocker, compared to the anti HER monoclonal antibody (mAb) ICR62 and first generation TKI erlotinib in inhibiting the growth of a panel of human pancreatic tumour cells [ 19].

In the age group of 75 years and older prescription rates for diuretics and digoxin were higher, but lower for beta-blockers compared to the under 75 group.

No study has investigated the effects of a combination of an angiotensin receptor blocker/calcium channel blocker compared to those of a calcium channel blocker/angiotensin-converting enzyme inhibitor combination.

The relative weak effects of Ca2+ channel blockers compared to that of Arabidopsis may also be due to our calculation method of aequorin luminescence signal.

This compares with the results seen in the later risk periods of our one year study period where there was a non-significant decrease in heart failure hospitalisations 4-84-8nths (RR, 0.76; 95% CI (0.57-1.02)) and a significant decrease >8 months, post-initiation of a beta blocker compared to baseline (RR, 0.62; 95% CI (0.39, 0.99)).

*Median (q1, q3) The results of the one year observation showed that in the post-exposure risk periods there was a significant increased risk before 2 weeks, a non-significant decrease 4-8 months and significant decrease in hospitalisations for heart failure 8-12 months post-initiation of beta blocker compared to baseline.

This was probably not secondary to attenuation of the response due to β-blockers as fewer diabetics with HbA1c ⩾8 were taking β-blockers compared to those with HbA1c <8.

33– 35 Newton et al 11 also observed a significantly less inotropic response to salbutamol in patients treated with β-blockers compared to those not using β-blockers.

Patients with ruptured VAAs were slightly less likely to be taking beta blockers compared to those with non-ruptured VAAs (35.1 % vs. 37.5 %, respectively).

At six months, 3 (21%) of the intervention group achieved optimal doses of combined ACEi and β-blockers compared to 00(0%) in the control group (p=0.250, see Table  2).

With regard to standard therapy for heart failure, our analysis revealed that more IMP obtained beta-blockers and/or ACE inhibitors/angiotensin-receptor-blockers (ARB) compared to the NIMP (Table  3).